The inflammatory gene pathway is not a major contributor to polycystic ovary snydrome

Surabhi Bhatt, Priscilla Mutharasan, Obed A. Garcia, Nadereh Jafari, Richard Legro, Andrea Dunaif, Margrit Urbanek

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Context: Although inflammation is clearly associated with obesity, diabetes, and insulin resistance, the role of chronic inflammation in the etiology of polycystic ovary syndrome (PCOS) is unclear. Objective: To determine whether chronic inflammation plays a causal role in the etiology of PCOS, we tested for an association between PCOS and genetic markers mapping to 80 members of the inflammatory pathway. Design: This was a case-control association study. Setting: The setting was an academic medical center. Patients or Participants: A total of 905 index case patients with PCOS and 955 control women (108 intensively phenotyped subjects with normal androgen levels and regular menses and 847 minimally phenotyped subjects with regular menses and no history of PCOS). Interventions: Subjects were genotyped at single nucleotide polymorphisms mapping to 80 inflammatory genes. Logistic regression was used to test for an association between 822 single nucleotide polymorphisms and PCOS after adjustment for population stratification, body mass index, and/or age. In the index patients, we also tested for association with 11 quantitative traits (body mass index and testosterone, fasting insulin, fasting glucose, 2-hour postchallenge glucose, LH, FSH, total cholesterol, high-density lipoprotein, low-density lipoprotein, and triglyceride levels). Main Outcome Measures: The evidence for an association with PCOS and with 11 quantitative traits was investigated. Results: Nominally significant evidence for an association was observed with MAP3K7, IKBKG, TNFRS11A, AKT2, IL6R, and IRF1, but no results remained statistically significant after adjustment for multiple testing. Conclusions: Genetic variation in the inflammatory pathway is not a major contributor to the etiology of PCOS or related quantitative traits in women with PCOS.

Original languageEnglish (US)
JournalJournal of Clinical Endocrinology and Metabolism
Volume99
Issue number3
DOIs
StatePublished - Jan 1 2014

Fingerprint

Polycystic Ovary Syndrome
Polymorphism
Ovary
Nucleotides
Genes
Insulin
Glucose
Medical problems
HDL Cholesterol
Androgens
Testosterone
Logistics
Testing
Menstruation
Inflammation
Single Nucleotide Polymorphism
Fasting
Nucleotide Mapping
Body Mass Index
Genetic Markers

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Bhatt, Surabhi ; Mutharasan, Priscilla ; Garcia, Obed A. ; Jafari, Nadereh ; Legro, Richard ; Dunaif, Andrea ; Urbanek, Margrit. / The inflammatory gene pathway is not a major contributor to polycystic ovary snydrome. In: Journal of Clinical Endocrinology and Metabolism. 2014 ; Vol. 99, No. 3.
@article{7fe1c2538d184fabaf2912a91c96cc52,
title = "The inflammatory gene pathway is not a major contributor to polycystic ovary snydrome",
abstract = "Context: Although inflammation is clearly associated with obesity, diabetes, and insulin resistance, the role of chronic inflammation in the etiology of polycystic ovary syndrome (PCOS) is unclear. Objective: To determine whether chronic inflammation plays a causal role in the etiology of PCOS, we tested for an association between PCOS and genetic markers mapping to 80 members of the inflammatory pathway. Design: This was a case-control association study. Setting: The setting was an academic medical center. Patients or Participants: A total of 905 index case patients with PCOS and 955 control women (108 intensively phenotyped subjects with normal androgen levels and regular menses and 847 minimally phenotyped subjects with regular menses and no history of PCOS). Interventions: Subjects were genotyped at single nucleotide polymorphisms mapping to 80 inflammatory genes. Logistic regression was used to test for an association between 822 single nucleotide polymorphisms and PCOS after adjustment for population stratification, body mass index, and/or age. In the index patients, we also tested for association with 11 quantitative traits (body mass index and testosterone, fasting insulin, fasting glucose, 2-hour postchallenge glucose, LH, FSH, total cholesterol, high-density lipoprotein, low-density lipoprotein, and triglyceride levels). Main Outcome Measures: The evidence for an association with PCOS and with 11 quantitative traits was investigated. Results: Nominally significant evidence for an association was observed with MAP3K7, IKBKG, TNFRS11A, AKT2, IL6R, and IRF1, but no results remained statistically significant after adjustment for multiple testing. Conclusions: Genetic variation in the inflammatory pathway is not a major contributor to the etiology of PCOS or related quantitative traits in women with PCOS.",
author = "Surabhi Bhatt and Priscilla Mutharasan and Garcia, {Obed A.} and Nadereh Jafari and Richard Legro and Andrea Dunaif and Margrit Urbanek",
year = "2014",
month = "1",
day = "1",
doi = "10.1210/jc.2013-2342",
language = "English (US)",
volume = "99",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "3",

}

The inflammatory gene pathway is not a major contributor to polycystic ovary snydrome. / Bhatt, Surabhi; Mutharasan, Priscilla; Garcia, Obed A.; Jafari, Nadereh; Legro, Richard; Dunaif, Andrea; Urbanek, Margrit.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 99, No. 3, 01.01.2014.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The inflammatory gene pathway is not a major contributor to polycystic ovary snydrome

AU - Bhatt, Surabhi

AU - Mutharasan, Priscilla

AU - Garcia, Obed A.

AU - Jafari, Nadereh

AU - Legro, Richard

AU - Dunaif, Andrea

AU - Urbanek, Margrit

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Context: Although inflammation is clearly associated with obesity, diabetes, and insulin resistance, the role of chronic inflammation in the etiology of polycystic ovary syndrome (PCOS) is unclear. Objective: To determine whether chronic inflammation plays a causal role in the etiology of PCOS, we tested for an association between PCOS and genetic markers mapping to 80 members of the inflammatory pathway. Design: This was a case-control association study. Setting: The setting was an academic medical center. Patients or Participants: A total of 905 index case patients with PCOS and 955 control women (108 intensively phenotyped subjects with normal androgen levels and regular menses and 847 minimally phenotyped subjects with regular menses and no history of PCOS). Interventions: Subjects were genotyped at single nucleotide polymorphisms mapping to 80 inflammatory genes. Logistic regression was used to test for an association between 822 single nucleotide polymorphisms and PCOS after adjustment for population stratification, body mass index, and/or age. In the index patients, we also tested for association with 11 quantitative traits (body mass index and testosterone, fasting insulin, fasting glucose, 2-hour postchallenge glucose, LH, FSH, total cholesterol, high-density lipoprotein, low-density lipoprotein, and triglyceride levels). Main Outcome Measures: The evidence for an association with PCOS and with 11 quantitative traits was investigated. Results: Nominally significant evidence for an association was observed with MAP3K7, IKBKG, TNFRS11A, AKT2, IL6R, and IRF1, but no results remained statistically significant after adjustment for multiple testing. Conclusions: Genetic variation in the inflammatory pathway is not a major contributor to the etiology of PCOS or related quantitative traits in women with PCOS.

AB - Context: Although inflammation is clearly associated with obesity, diabetes, and insulin resistance, the role of chronic inflammation in the etiology of polycystic ovary syndrome (PCOS) is unclear. Objective: To determine whether chronic inflammation plays a causal role in the etiology of PCOS, we tested for an association between PCOS and genetic markers mapping to 80 members of the inflammatory pathway. Design: This was a case-control association study. Setting: The setting was an academic medical center. Patients or Participants: A total of 905 index case patients with PCOS and 955 control women (108 intensively phenotyped subjects with normal androgen levels and regular menses and 847 minimally phenotyped subjects with regular menses and no history of PCOS). Interventions: Subjects were genotyped at single nucleotide polymorphisms mapping to 80 inflammatory genes. Logistic regression was used to test for an association between 822 single nucleotide polymorphisms and PCOS after adjustment for population stratification, body mass index, and/or age. In the index patients, we also tested for association with 11 quantitative traits (body mass index and testosterone, fasting insulin, fasting glucose, 2-hour postchallenge glucose, LH, FSH, total cholesterol, high-density lipoprotein, low-density lipoprotein, and triglyceride levels). Main Outcome Measures: The evidence for an association with PCOS and with 11 quantitative traits was investigated. Results: Nominally significant evidence for an association was observed with MAP3K7, IKBKG, TNFRS11A, AKT2, IL6R, and IRF1, but no results remained statistically significant after adjustment for multiple testing. Conclusions: Genetic variation in the inflammatory pathway is not a major contributor to the etiology of PCOS or related quantitative traits in women with PCOS.

UR - http://www.scopus.com/inward/record.url?scp=84895824547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895824547&partnerID=8YFLogxK

U2 - 10.1210/jc.2013-2342

DO - 10.1210/jc.2013-2342

M3 - Article

C2 - 24423322

AN - SCOPUS:84895824547

VL - 99

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 3

ER -